Indonesia’s healthcare expenditure is predicted to reach US$60.6 billion in 2018 with a growth rate of 14.9 percent over the 2012-2018 period.
Overall, Indonesia still has poor sanitation and it is difficult to obtain clean water outside of the major cities. For these reasons, diarrhea, gastroenteritis, and contagious diseases such as typhoid, paratyphoid fever, dengue fever, and malaria are still widespread. In addition, according to the World Trade Organization, about 70% of men over the age of 20 in Indonesia are smokers, which leads to an increase of non-communicable diseases such as cancer, stroke, heart disease, and diabetes, and raises the requirements for chronic disease-related products. Indonesia’s doctor-to-patient ratio is only 3 doctors per 10,000 people, much less than Malaysia, which has 9 doctors for every 10,000 people, or Cuba, which has 64 doctors for 10,000 people. Indonesia currently has around 73 medical facilities across the country, but lacks doctors, particularly specialists doctors.
According to the National Agency for Drug and Food Control, 3,231 new food supplements were registered in 2013 in Indonesia. Indonesia currently has approximately 200 pharmaceutical companies.
Indonesia has limited production of primary medical products, therefore imports of medical products are very important and supply about 97.2 % of needed products. Nonetheless, foreign companies face many obstacles and registration is required.
Indonesia is home to 240 million people and is one of the fastest growing pharmaceutical markets in Asia. The market was worth US $5 billion in 2012, roughly the same size as the pharmaceutical market in Taiwan.
Feel free to contact us and for a free quotation on entering the healthcare sector in Indonesia.
Fill the form below and we’ll reply you with a quote and overview of the process your industry.